Neil Woodford

EQS-News: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer

Retrieved on:

Donnerstag, März 16, 2023

Research, FSE, Corporate communication, J. P. Morgan, Jefferies, Neil Woodford, University College London, Financial Oversight and Management Board for Puerto Rico, Patient, Ta Sung Lee, Goldman Sachs, Strategic management, Security (finance), Management, Physiology, Pharmacology, MorphoSys

MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced today that Lucinda Crabtree, Ph.D., will join MorphoSys as Chief Financial Officer and member of the Management Board, succeeding Sung Lee.

Key Points:

MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced today that Lucinda Crabtree, Ph.D., will join MorphoSys as Chief Financial Officer and member of the Management Board, succeeding Sung Lee.
“I am pleased to welcome Lucinda to MorphoSys as our new Chief Financial Officer,” said Marc Cluzel, M.D., Ph.D., Chairman of the MorphoSys Supervisory Board.
“Lucinda will bring a strong skill set to MorphoSys with her broad biotech experience in corporate roles, as an analyst and investment professional, and the impact she has made in leading finance, strategy and investor relations divisions.”
Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, added: “Lucinda has achieved tremendous success in designing and executing financial and business transactions.
“MorphoSys has successfully honed its focus on oncology and has a strong cash position to execute on their great opportunities.”
Lucinda Crabtree joins MorphoSys from Autolus Therapeutics, a clinical-stage biopharmaceutical company developing T cell therapies, where she most recently served as Chief Financial Officer.

Autolus Therapeutics announces retirement of chief financial officer and succession plan

Retrieved on:

Montag, Januar 10, 2022

LONDON, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced that Andrew J. Oakley plans to retire from his position as chief financial officer with effect from 31 March 2022 and will concentrate on non-executive director roles. He currently serves on the Boards of Union Therapeutics A/S and Novaremed AG. Andrew will remain a senior advisor to Autolus until March 2023. Dr. Lucinda Crabtree, senior vice president of finance at Autolus, will be appointed chief financial officer following his retirement.

Key Points:

Dr. Lucinda Crabtree, senior vice president of finance at Autolus, will be appointed chief financial officer following his retirement.
I want to thank Andrew for his years of service to Autolus as chief financial officer and for the impact he has had on the Company and the patients we serve, said Dr. Christian Itin, chief executive officer of Autolus.
It has been a privilege to serve as CFO of Autolus since 2018 and to support the company to a pivotal stage with its lead candidate, obe-cel," said Andrew Oakley, chief financial officer of Autolus.
Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.

Treasury Committee comments on Woodford Fund

Retrieved on:

Mittwoch, Oktober 16, 2019

Neil Woodford, Woodford, Catherine McKinnell, British MPs

It has been announced today that the Woodford Equity Income Fund will be liquidated, with Neil Woodford ceasing to be its investment manager with immediate effect.

Key Points:

It has been announced today that the Woodford Equity Income Fund will be liquidated, with Neil Woodford ceasing to be its investment manager with immediate effect.
Commenting on the announcement, Catherine McKinnell MP, Interim Chair of the Treasury Committee, said:
This appears to the beginning of the end of a sorry state of affairs.
This will have been a troubling time for investors in the Woodford Fund, who may not get any money back until at least January.
Im sure the Committee will want to examine what lessons can be learned from this saga.

Treasury Committee comments on Woodford Fund

Retrieved on:

Mittwoch, Oktober 16, 2019

Neil Woodford, Woodford, Catherine McKinnell, British MPs

It has been announced today that the Woodford Equity Income Fund will be liquidated, with Neil Woodford ceasing to be its investment manager with immediate effect.

Key Points:

It has been announced today that the Woodford Equity Income Fund will be liquidated, with Neil Woodford ceasing to be its investment manager with immediate effect.
Commenting on the announcement, Catherine McKinnell MP, Interim Chair of the Treasury Committee, said:
This appears to the beginning of the end of a sorry state of affairs.
This will have been a troubling time for investors in the Woodford Fund, who may not get any money back until at least January.
Im sure the Committee will want to examine what lessons can be learned from this saga.

Treasury Committee comments on Woodford Fund

Retrieved on:

Mittwoch, Oktober 16, 2019

Neil Woodford, Woodford, Catherine McKinnell, British MPs

It has been announced today that the Woodford Equity Income Fund will be liquidated, with Neil Woodford ceasing to be its investment manager with immediate effect.

Key Points:

It has been announced today that the Woodford Equity Income Fund will be liquidated, with Neil Woodford ceasing to be its investment manager with immediate effect.
Commenting on the announcement, Catherine McKinnell MP, Interim Chair of the Treasury Committee, said:
This appears to the beginning of the end of a sorry state of affairs.
This will have been a troubling time for investors in the Woodford Fund, who may not get any money back until at least January.
Im sure the Committee will want to examine what lessons can be learned from this saga.